Ruiyu Cao1, Xilei Ban2, Hongwei Li1, Aiqi Sun3, Peng Wu4, Mingfeng Xia5, Hua Bian5, Hao Li1, and He Wang1
1Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China, 2Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan University, Shanghai, China, 3Oden Institute for Computational Engineering and Sciences, University of Texas at Austin, Austin, TX, United States, 4Philips Healthcare, Shanghai, China, 5Department of Endocrinology and Metabolism, Zhongshan Hospital, Fudan Institute for Metabolic Disease, Human Phenome Institute, Fudan University, Shanghai, China
Synopsis
Keywords: Liver, Liver
Motivation: Steatosis is the histopathologic hallmark of NAFLD. Liver histology is currently the standard for hepatic steatosis diagnosis, which is invasive. Several MRI methods have been validated to accurately measure hepatic fat content.
Goal(s): To evaluate diagnostic performance of different hepatic fat quantification methods.
Approach: We compared hepatic fat content calculated by Dixon MRI and MRS with histology results as reference.
Results: The outcomes show that the fat fraction measured by these two methods highly correlated with steatosis degrades measured by histology. Compared with MRS, fat fraction calculated by Dixon MRI performed better diagnostic capacity in hepatic steatosis.
Impact: Our study demonstrates that the Dixon-based
method outperforms the MRS. The use of whole liver automatic segmentation
improves diagnostic efficiency, and its performance is comparable to the
ROI-based method, making it a promising hepatic fat fraction detection approach
in clinic.
Introduction
Hepatic fat content
is a significant indicator for diagnosing nonalcoholic fatty liver disease (NAFLD).
Current standard for fat fraction quantification is hepatic biopsy, which is
invasive [1]. Both Magnetic Resonance Spectroscopy (MRS) and Dixon-based Magnetic
Resonance Imaging (MRI) have demonstrated their ability to precisely measure hepatic
fat fraction [2].
Dixon-based
methods offer
the
advantage of providing full liver coverage during acquisition, making execution
and analysis easier [3]. Our aim is to evaluate the diagnostic performance of hepatic
steatosis using different MRI methods (Dixon MRI and MRS), with liver biopsy as
the reference standard. In Dixon-based MRI, we used both manually labeled ROI
and fully automatic whole liver segmentation (WLS) to measure hepatic proton
density fat fraction (PDFF). The diagnostic performance of the automatic method
was also investigated compared to manual ROI and MRS.Materials and Methods
The workflow of
the methods is demonstrated in Figure 1.
Data Acquisition
The
study had the a priori approval from the institutional review boards of
the Zhongshan Hospital Fudan University. We recruited 61 patients with
clinically confirmed or suspected NAFLD. All participants received liver biopsy
and underwent MR scans on a 3T Philips Ingenia CX scanner (Philips, Best, The Netherlands).
The imaging protocol included a pointed-resolved MRS sequence (single-voxel
size = 2×2×2cm3 , TR/TE = 2000/50ms, Flip
angle = 90°, scan duration = 16s ), and an axial three-dimensional
multi-echo modified Dixon gradient echo sequence (resolution = 2.27×2.27×3mm3,
echo train = 6, flip angle = 3°, number of slices = 80).
Imaging Processing
The data of MRS
were interpreted using Philips software by an experienced reader who was
blinded to MRI and histologic results. MRS PDFF was calculated as the area of
peak fat divided by the sum of the peak water and fat areas, then multiplied by
100.
Dixon-based PDFF
was obtained using two methods. The first one used manual ROIs. Five ROIs were manually
labeled using the Philips Interspace Portal, avoiding large vessels, ducts, and
hepatic lesions. One representative region was selected for evaluating the
whole liver fat fraction. The second method used automated whole liver
segmentation (WLS). We employed 3d_fullres nnUnet [4] with the TrainerV2_DA3 strategy
to train 435 Dixon images acquired from Shanghai Panorama Medical Imaging
Center, Zhongshan Hospital and Ruijin Hospital for liver segmentation. The
segmented whole liver regions were used to calculate averaged liver fat
fraction.
Statistical Analysis
Data analysis was
carried out using R software version 4.3.2. Correlations between PDFF measured
by three methods and histologic steatosis grades were assessed by using
Spearman correlation coefficient. Receiver operating characteristic (ROC)
analysis was performed to evaluate the diagnostic performance of the three
methods. Cutoff values with specificity greater than 90% were selected to
rule-in different grades of hepatic steatosis. The DeLong test was used to
compare the area under the receiver operating characteristic curves (AUCs) of ROI,
WLS and MRS.Results
A total of 61
participants were included (39 male, 41.59 ±
13.78 years) (Figure 2).
PDFF measured by all the three methods demonstrated a strong correlation with
histology steatosis degrades (rs = 0.79 p<0.001, rs
= 0.73 p<0.001, and rs = 0.64 p<0.001, respectively) (Figure 3). Results of Dixon-based two methods
showed similar diagnostic performance for steatosis grading (ROI AUC, 0.922;
WLS AUC, 0.899), and both were more accurate than MRS (MRS AUC, 0.827) (Figure 4).
The ROI cutoff values for ruling-in S1, S2 and S3 were 6.67, 10.3 and 23.67
(%), respectively, and the cutoff values for another two methods are
demonstrated in Figure 5.Discussion
The cutoff
values for different steatosis grades, which exhibited high specificity, were
similar to previous studies [5][6][7]. The MRS had a high threshold for the
diagnosis of hepatic steatosis compared to previous study [8], in part owing to
the sampling error (i.e., quality of voxel placement) and the inclusion of
patients known or suspected NAFLD, rather
than healthy volunteers. The cutoff values
calculated by MRS at S2-3 and S3 are consistent with previous studies [9].
The cutoff values
for different hepatic steatosis grades provided in our study offers insights for
clinical application of Dixon based PDFF.Conclusion
Dixon-based method
outperforms MRS in diagnostic performance for hepatic steatosis, while the performance
of WLS PDFF is similar to that of manual ROI PDFF. The WLS approach is promising to improve the
efficiency of clinical diagnosis while maintaining a high accuracy of hepatic
fat fraction.Acknowledgements
No acknowledgement found.References
[1] Martí-Aguado D, Jiménez-Pastor A,
Alberich-Bayarri Á, et al. Automated whole-liver MRI segmentation to assess
steatosis and iron quantification in chronic liver disease[J]. Radiology, 2022,
302(2): 345-354.
[2] Kang B K, Kim M, Song S Y, et al.
Feasibility of modified Dixon MRI techniques for hepatic fat quantification in
hepatic disorders: validation with MRS and histology[J]. The British journal of
radiology, 2017, 91(1089): 20170378.
[3] Brancato V, Della Pepa G, Bozzetto L, et
al. Evaluation of a Whole-Liver Dixon-Based MRI Approach for Quantification of
Liver Fat in Patients with Type 2 Diabetes Treated with Two Isocaloric
Different Diets[J]. Diagnostics, 2022, 12(2): 514.
[4] Isensee F, Jaeger P F, Kohl S A A, et al.
nnU-Net: a self-configuring method for deep learning-based biomedical image
segmentation[J]. Nature methods, 2021, 18(2): 203-211.
[5] Tang A,
Desai A, Hamilton G, et al. Accuracy of MR imaging-estimated proton density fat
fraction for classification of dichotomized histologic steatosis grades in
nonalcoholic fatty liver disease. Radiology. 2015;274(2):416-425.
[6] Middleton MS, Van Natta ML, Heba ER, et al.
Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat
fraction in pediatric nonalcoholic fatty liver disease. Hepatology.
2018;67(3):858-872.
[7] Middleton MS, Heba ER, Hooker CA, et al.
Agreement Between Magnetic Resonance Imaging Proton Density Fat Fraction
Measurements and Pathologist-Assigned Steatosis Grades of Liver Biopsies From
Adults With Nonalcoholic Steatohepatitis. Gastroenterology. 2017;153(3):753-761.
[8] Szczepaniak LS, Nurenberg P, Leonard D, et
al. Magnetic resonance spectroscopy to measure hepatic triglyceride content:
prevalence of hepatic steatosis in the general population. Am J Physiol
Endocrinol Metab. 2005;288(2):E462-E468.
[9] Georgoff P, Thomasson D, Louie A,
Fleischman E, Dutcher L, Mani H, Kottilil S, Morse C, Dodd L, Kleiner D,
Hadigan C. Hydrogen-1 MR spectroscopy for measurement and diagnosis of hepatic
steatosis. AJR Am J Roentgenol. 2012 Jul;199(1):2-7.